Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2006

01.12.2006 | Review Article

The impact of informing psychiatric patients about their medication: a systematic review

verfasst von: Franciska A. M. Desplenter, Steven Simoens, Gert Laekeman

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Aim

This literature study explores the impact of educational interventions about medicines for psychiatric patients on adherence, knowledge and economic, clinical and humanistic outcomes.

Method

A systematic review of eight electronic databases was carried out. Reference lists of primary studies were searched. Studies measuring the impact of medication information for adult psychiatric patients in an individual way on adherence, knowledge, economic, clinical and humanistic outcomes were included. Data analysis and assessment of methodological quality were executed according to the Cochrane Collaboration guidelines. A meta-analysis of primary studies was not suitable due to the heterogeneity of the primary studies.

Results

Literature search generated 17 studies. Thirteen studies measured adherence, seven of which reported an increase. Generally, adherence was 11–30% higher in the intervention groups than in the control group. A combination of oral and written information seemed to have an added value as compared with supplying exclusively oral or written information. The provision of easily readable written information improved adherence by 11%. Seven of the eight studies measuring knowledge reported an overall improvement. Knowledge was increased with 14–28% in interventions groups in comparison with control group. One study reported an increased satisfaction. No significant differences were seen for frequency of side-effects, relapse or admission rates, symptoms and quality of life. Not one of the 17 studies explored the economic impact of the educational intervention. The methodological quality of the included studies was variable. Individual studies suffered from a variety of biases and other methodological limitations.

Conclusion

The included studies suggested a positive impact on adherence and knowledge. As only one study assessed patient’s satisfaction, no definitive conclusions can be made. No significant differences were observed for frequency of side-effects, relapse or admission rates, symptoms and quality of life. Studies on the cost-effectiveness of such interventions need to be performed. In general, more well-designed studies with good methodological quality in this research domain are needed.
Literatur
1.
Zurück zum Zitat World Health Organisation, Fact sheet No 265. The World Health Report 2001 on mental and neurological disorders, December 2001. http://www.who.int/mediacentre/factsheets/fs265/en/ (2 September 2004). World Health Organisation, Fact sheet No 265. The World Health Report 2001 on mental and neurological disorders, December 2001. http://​www.​who.​int/​mediacentre/​factsheets/​fs265/​en/​ (2 September 2004).
2.
Zurück zum Zitat Lépine JP, Gastpar M, Mendlewicz J, Tylee A. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 1997;12:19–29.PubMedCrossRef Lépine JP, Gastpar M, Mendlewicz J, Tylee A. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 1997;12:19–29.PubMedCrossRef
3.
Zurück zum Zitat Bromet EJ, Fennig S. Epidemiology and natural history of schizophrenia. Biol Psychiatry 1999;46:871–81PubMedCrossRef Bromet EJ, Fennig S. Epidemiology and natural history of schizophrenia. Biol Psychiatry 1999;46:871–81PubMedCrossRef
4.
Zurück zum Zitat Angunawela II, Mullee MA. Drug information for the mentally ill: a randomized controlled trial. Int J Psych Clin Pract 1998;38:121–7. Angunawela II, Mullee MA. Drug information for the mentally ill: a randomized controlled trial. Int J Psych Clin Pract 1998;38:121–7.
5.
Zurück zum Zitat Rheinstein PH, McGinnis TJ, Nightingale SL. The patient information and education initiative. Am Fam Physician 1995;52(8):2377–82.PubMed Rheinstein PH, McGinnis TJ, Nightingale SL. The patient information and education initiative. Am Fam Physician 1995;52(8):2377–82.PubMed
6.
Zurück zum Zitat Keller MB, Hirschfeld RMA, Demyttenaere K, Baldwin DS. Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol 2002;17:265–71.PubMedCrossRef Keller MB, Hirschfeld RMA, Demyttenaere K, Baldwin DS. Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol 2002;17:265–71.PubMedCrossRef
7.
Zurück zum Zitat Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. The Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD000011. DOI: 10.1002/14651858.CD000011. This version first published online: 22 April 2002 in Issue 2, 2002. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. The Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD000011. DOI: 10.1002/14651858.CD000011. This version first published online: 22 April 2002 in Issue 2, 2002.
8.
Zurück zum Zitat Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry 2002;180:104–9.PubMedCrossRef Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry 2002;180:104–9.PubMedCrossRef
9.
Zurück zum Zitat Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol 2003;23(4):389–99PubMedCrossRef Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol 2003;23(4):389–99PubMedCrossRef
10.
Zurück zum Zitat Deijen JB, Kornaat H, Cloin PA. The effect of brochures and audiotape on efficacy and tolerability of venlafaxine in depressed outpatients: a single-blind parallel study in general practice. J Clin Psychiatry 2000;2:89–95. Deijen JB, Kornaat H, Cloin PA. The effect of brochures and audiotape on efficacy and tolerability of venlafaxine in depressed outpatients: a single-blind parallel study in general practice. J Clin Psychiatry 2000;2:89–95.
11.
Zurück zum Zitat Fawcett J. Compliance: definitions and key issues. J Clin Psychiatry 1995;56(S1): S4–10. Fawcett J. Compliance: definitions and key issues. J Clin Psychiatry 1995;56(S1): S4–10.
12.
Zurück zum Zitat Thase ME. The clinical, psychosocial and pharmacoeconomic ramifications of remission. Am J Manag Care 2001;7(11):S377–85.PubMed Thase ME. The clinical, psychosocial and pharmacoeconomic ramifications of remission. Am J Manag Care 2001;7(11):S377–85.PubMed
13.
Zurück zum Zitat Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med 1984;100:258–68.PubMed Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med 1984;100:258–68.PubMed
14.
Zurück zum Zitat Morris LA, Halperin JA. Effects of written drug information on patient knowledge and compliance: a literature review. Am J Public Health 1979;69:47–52.PubMed Morris LA, Halperin JA. Effects of written drug information on patient knowledge and compliance: a literature review. Am J Public Health 1979;69:47–52.PubMed
15.
Zurück zum Zitat Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383–6.PubMedCrossRef Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383–6.PubMedCrossRef
16.
Zurück zum Zitat McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002;288:2868–79.PubMedCrossRef McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002;288:2868–79.PubMedCrossRef
17.
Zurück zum Zitat Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002;159:1653–64.PubMedCrossRef Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002;159:1653–64.PubMedCrossRef
18.
Zurück zum Zitat Vergouwen AC, Bakker A, Katon WJ, Verheij TJ, Koerselman F. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry 2003;64:1415–20.PubMedCrossRef Vergouwen AC, Bakker A, Katon WJ, Verheij TJ, Koerselman F. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry 2003;64:1415–20.PubMedCrossRef
19.
Zurück zum Zitat Roter D, Hall J, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998;36(8):1138–61.PubMedCrossRef Roter D, Hall J, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998;36(8):1138–61.PubMedCrossRef
20.
Zurück zum Zitat Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999;37:113–24.PubMedCrossRef Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999;37:113–24.PubMedCrossRef
21.
Zurück zum Zitat Jasti S, Siega-Riz AM, Cogswell ME, Hartzema AG. Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr 2006;136:479–83.PubMed Jasti S, Siega-Riz AM, Cogswell ME, Hartzema AG. Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr 2006;136:479–83.PubMed
22.
Zurück zum Zitat Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res 2000;42:241–7.PubMedCrossRef Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res 2000;42:241–7.PubMedCrossRef
23.
Zurück zum Zitat Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewers’ Handbook 4.2.2. [updated March 2004]. http://www.cochrane.org/resources/handbook/hbook.htm (accessed 4th November 2004) Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewers’ Handbook 4.2.2. [updated March 2004]. http://​www.​cochrane.​org/​resources/​handbook/​hbook.​htm (accessed 4th November 2004)
24.
Zurück zum Zitat Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information leaflets and counselling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Pract 2005;13:123–31.CrossRef Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information leaflets and counselling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Pract 2005;13:123–31.CrossRef
25.
Zurück zum Zitat Azrin NH, Teichner G. Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behav Res Ther 1998;36:849–61PubMedCrossRef Azrin NH, Teichner G. Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behav Res Ther 1998;36:849–61PubMedCrossRef
26.
Zurück zum Zitat Chaplin R, Kent A. Informing patients about tardive dyskinesia: controlled trial of patient education. Br J Psychiatry 1998;172:78–81.PubMed Chaplin R, Kent A. Informing patients about tardive dyskinesia: controlled trial of patient education. Br J Psychiatry 1998;172:78–81.PubMed
27.
Zurück zum Zitat Kleinman I, Schachter D, Koritar E. Informed consent and tardive dyskinesia. Am J Psychiatry 1989;146(7):902–4.PubMed Kleinman I, Schachter D, Koritar E. Informed consent and tardive dyskinesia. Am J Psychiatry 1989;146(7):902–4.PubMed
28.
Zurück zum Zitat Kleinman I, Schachter D, Jeffries J, Goldhamer P. Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication. Hosp Community Psychiatry 1993;44(12):1189–91. Kleinman I, Schachter D, Jeffries J, Goldhamer P. Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication. Hosp Community Psychiatry 1993;44(12):1189–91.
29.
Zurück zum Zitat Ley P, Jain VK, Skilbeck CE. A method for decreasing patients’ medication errors. Psychol Med 1976;6(4):599–601.PubMed Ley P, Jain VK, Skilbeck CE. A method for decreasing patients’ medication errors. Psychol Med 1976;6(4):599–601.PubMed
30.
Zurück zum Zitat Macpherson R, Jerrom B, Hughes A. A controlled study of education about drug treatment in schizophrenia. Br J Psychiatry 1996;168(6):709–17.PubMedCrossRef Macpherson R, Jerrom B, Hughes A. A controlled study of education about drug treatment in schizophrenia. Br J Psychiatry 1996;168(6):709–17.PubMedCrossRef
31.
Zurück zum Zitat Munetz MR, Roth LH. Informing patients about tardive dyskinesia. Arch Gen Psychiatry 1985;42(9):866–71.PubMed Munetz MR, Roth LH. Informing patients about tardive dyskinesia. Arch Gen Psychiatry 1985;42(9):866–71.PubMed
32.
Zurück zum Zitat Myers ED, Calvert EJ. The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on amitriptyline. Br J Psychiatry 1973;122:461–4.PubMed Myers ED, Calvert EJ. The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on amitriptyline. Br J Psychiatry 1973;122:461–4.PubMed
33.
Zurück zum Zitat Myers ED, Calvert EJ. The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on dothiepin. J Int Med Res 1976;4(4):237–40.PubMed Myers ED, Calvert EJ. The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on dothiepin. J Int Med Res 1976;4(4):237–40.PubMed
34.
Zurück zum Zitat Myers ED, Calvert EJ. Knowledge of side-effects and perseverance with medication. Br J Psychiatry 1978;132:526–7.PubMedCrossRef Myers ED, Calvert EJ. Knowledge of side-effects and perseverance with medication. Br J Psychiatry 1978;132:526–7.PubMedCrossRef
35.
Zurück zum Zitat Myers ED, Calvert EJ. Information, compliance and side-effects: a study of patients on antidepressants medication. Br J Clin Pharmacol 1984;17(1):21–5.PubMed Myers ED, Calvert EJ. Information, compliance and side-effects: a study of patients on antidepressants medication. Br J Clin Pharmacol 1984;17(1):21–5.PubMed
36.
Zurück zum Zitat Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ 1999;319:612–5.PubMed Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ 1999;319:612–5.PubMed
37.
Zurück zum Zitat Robinson GL, Gilbertson AD, Litwack L. The effects of a psychiatric patient education to medication program on post-discharge compliance. Psychiatr Q 1986–87;58(2):113–8.CrossRef Robinson GL, Gilbertson AD, Litwack L. The effects of a psychiatric patient education to medication program on post-discharge compliance. Psychiatr Q 1986–87;58(2):113–8.CrossRef
38.
Zurück zum Zitat Wilkinson G, Allen P, Marshall E, Walker J, Browne W, Mann AH. The role of the practice nurse in the management of depression in general practice: treatment adherence to antidepressant medication. Psychol Med 1993;23(1):229–37.PubMedCrossRef Wilkinson G, Allen P, Marshall E, Walker J, Browne W, Mann AH. The role of the practice nurse in the management of depression in general practice: treatment adherence to antidepressant medication. Psychol Med 1993;23(1):229–37.PubMedCrossRef
39.
Zurück zum Zitat Oei TP, KazmierczakT. Factors associated with dropout in a group cognitive behaviour therapy for mood disorders. Behav Res Ther 1997;35(11):1025–30.PubMedCrossRef Oei TP, KazmierczakT. Factors associated with dropout in a group cognitive behaviour therapy for mood disorders. Behav Res Ther 1997;35(11):1025–30.PubMedCrossRef
40.
Zurück zum Zitat Anderson IM. SSRIS versus tricyclic antidepressants in depressed patients: a meta-analysis of efficacy and tolerability. Depress Anxiety 1998;7(S1):11–7.PubMedCrossRef Anderson IM. SSRIS versus tricyclic antidepressants in depressed patients: a meta-analysis of efficacy and tolerability. Depress Anxiety 1998;7(S1):11–7.PubMedCrossRef
41.
Zurück zum Zitat Brown CS, Wright RG, Christensen DB. Association between type of medication instruction and patients’ knowledge, side effects and compliance. Hosp Community Psychiatry 1987;38(1):55–60.PubMed Brown CS, Wright RG, Christensen DB. Association between type of medication instruction and patients’ knowledge, side effects and compliance. Hosp Community Psychiatry 1987;38(1):55–60.PubMed
42.
Zurück zum Zitat Coulter A: Evidence based patient information. BMJ 1998;317:225–6.PubMed Coulter A: Evidence based patient information. BMJ 1998;317:225–6.PubMed
43.
Zurück zum Zitat Coles GS, Roth L, Pollack IW. Literacy skills of long-term hospitalized mental patients. Hosp Community Psychiatry 1978;29(8):512–6.PubMed Coles GS, Roth L, Pollack IW. Literacy skills of long-term hospitalized mental patients. Hosp Community Psychiatry 1978;29(8):512–6.PubMed
44.
Zurück zum Zitat Berg A, Hammitt KB. Assessing the psychiatric patient’s ability to meet the literacy demands of hospitalization. Hosp Community Psychiatry 1980;31(4):266–8.PubMed Berg A, Hammitt KB. Assessing the psychiatric patient’s ability to meet the literacy demands of hospitalization. Hosp Community Psychiatry 1980;31(4):266–8.PubMed
45.
Zurück zum Zitat O’Neil CK, Poirer TI. Impact of patient knowledge, patient–pharmacist relationship, and drug perceptions on adverse drug therapy outcomes. Pharmacotherapy 1998;18(2):333–40.PubMed O’Neil CK, Poirer TI. Impact of patient knowledge, patient–pharmacist relationship, and drug perceptions on adverse drug therapy outcomes. Pharmacotherapy 1998;18(2):333–40.PubMed
46.
Zurück zum Zitat Frank E. Enhancing patient outcomes: treatment adherence. J Clin Psychiatry 1997; 58 Suppl 1: 11–4.PubMed Frank E. Enhancing patient outcomes: treatment adherence. J Clin Psychiatry 1997; 58 Suppl 1: 11–4.PubMed
Metadaten
Titel
The impact of informing psychiatric patients about their medication: a systematic review
verfasst von
Franciska A. M. Desplenter
Steven Simoens
Gert Laekeman
Publikationsdatum
01.12.2006
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2006
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-006-9054-2

Weitere Artikel der Ausgabe 6/2006

International Journal of Clinical Pharmacy 6/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.